Join the club for FREE to access the whole archive and other member benefits.

Longevity therapeutics: AI discovery of dual-purpose aging & disease drugs

Online event about harnessing the power of AI to improve the discovery process for drugs by OSAL with Alex Zhavoronkov (FREE)

24-Oct-2022

Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leading clinical-stage biotechnology company developing next-generation artificial intelligence and robotics platforms for drug discovery. He is also the founder of Deep Longevity, Inc, a spin-off of Insilico Medicine developing a broad range of artificial intelligence-based biomarkers of aging and longevity servicing healthcare providers and life insurance industry. In 2020 Deep Longevity was acquired by Endurance Longevity (HK: 0575).

Since 2014 he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for the generation of novel molecular structures with the desired properties and generation of synthetic biological and patient data. He also pioneered the applications of deep learning technologies for the prediction of human biological age using multiple data types, transfer learning from aging into disease, target identification, and signaling pathway modeling. Under his leadership, Insilico raised over $415 million in multiple rounds from expert investors, opened R&D centers in six countries or regions, partnered with multiple pharmaceutical, biotechnology, and academic institutions, nominated 8 preclinical candidates, and entered human clinical trials with AI-discovered novel target and AI-designed novel molecule.

Visit website: https://www.eventbrite.co.uk/e/longevity-therapeutics-ai-discovery-of-dual-purpose-aging-disease-drugs-tickets-437154108707

See also: Institute Oxford Society of Ageing and Longevity (OSAL) - Oxford University student group considers a world in which people regularly live past 100

Details last updated 20-Oct-2022

Interested in more events? View the club's event calendar.

Mentioned in this Resource

Alex Zhavoronkov

CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation